ROANOKE, VA – July 21, 2023 – Imbucanna, Inc., Virginia’s premier and only full-service contract manufacturer for superior quality, solid… Read More
ROANOKE, VA – July 21, 2023 – Imbucanna, Inc., Virginia’s premier and only full-service contract manufacturer for superior quality, solid dose cannabis products, is proud to announce the appointment of Dr. Matthew Hemberger as Chief Technical Officer, and Luke Marine as Quality Control Manager.
Dr. Hemberger, a pharmaceutical industry veteran with diverse experience across multiple dosage forms and development strategies, brings his expertise to Imbucanna while continuing his valuable work as Senior Director of Chemistry, Manufacturing, and Controls (CMC) and Quality at ImmunoGenesis. Prior to his leadership role at ImmunoGenesis, he held various positions at GlaxoSmithKline (GSK), notably as the Director of Data Integrity for the GSK-Pfizer joint venture. His broad expertise includes global manufacturing, supply, asset commercialization, inspections, and regulatory responses.
Dr. Hemberger’s track record boasts significant contributions to the development of various high-profile pharmaceutical products, including Horizant, Cabenuva/Vocabria, and Blenrep. He began his professional journey at Mylan Pharmaceuticals in their Product Development group. Dr. Hemberger earned his PhD in Analytical Chemistry from Florida State University, and his BS in Chemistry from Viterbo University.
Luke Marine, the newly appointed Quality Control Manager, is a Roanoke College graduate with a BS in Chemistry and a minor in Mathematics. Prior to joining Imbucanna, Marine served as the QA/QC Manufacturing Supervisor Chemist in the cosmetics sector, where he ensured compliance with rigorous manufacturing regulations and the maintenance of high product quality standards.
“The addition of Dr. Hemberger and Luke Marine marks an exciting new chapter for Imbucanna,” said Leo Mendez, the CEO of Imbucanna, Inc. “Their diverse experience and innovative approaches to quality control and scientific leadership will be instrumental in our commitment to deliver safe, superior-quality cannabis products.”
Imbucanna, Inc. upholds its pledge to produce high-quality hemp-derived products, supported by its comprehensive in-house analytical laboratory tests and an FDA-registered facility adhering to strict Good Manufacturing Practices (GMP).
About Imbucanna, Inc.
Imbucanna, Inc., based in Roanoke, Virginia, specializes in the production of custom-manufactured, solid dosage products for the legal cannabis market. Founded in 2019, the company caters to the rapidly evolving industry with its patent-pending intermediates to facilitate cannabinoid solid dose formulations. For more information, visit https://imbucanna.com.
Rebecca D. Dillon
Executive Assistant to the CEO